1. Short title This Act may be cited as the Protect Our Military Children Act . 2. Pilot program for blood testing of certain children to determine exposure to perfluoroalkyl and poly­fluo­ro­al­kyl substances (a) Pilot program (1) In general During the period preceding October 1, 2023, the Secretary of Defense, acting through the Defense Health Agency, shall carry out a pilot program under which the Secretary provides blood testing to a covered child to determine and document the potential exposure of the child to perfluoroalkyl and polyfluoroalkyl substances (commonly known as PFAS ). The Secretary shall provide such testing at military medical treatment facilities at locations selected pursuant to subsection (b). (2) Standards The Secretary shall carry out the blood testing under paragraph (1) in accordance with standards established by the Agency for Toxic Substances and Disease Registry of the Centers for Disease Control and Prevention. (b) Locations The Secretary shall select military installations at which to carry out the pilot program under subsection (a)(1). A criterion in making such selection shall be whether the military installation has a high rate of covered children who receive health care at military medical treatment facilities at the installation. (c) Results In carrying out the pilot program under subsection (a)(1), the Secretary shall provide the results of a blood test of a covered child to the parent or guardian of the child. (d) Outreach The Secretary shall conduct outreach at military installations at which the pilot program under subsection (a)(1) is carried out to encourage participation in the pilot program, including by notifying members of the Armed Forces and dependents who live on or near such installations of— (1) the background on perfluoroalkyl and poly­fluo­ro­al­kyl substances; (2) the availability of blood tests under the pilot program